Literature DB >> 17450144

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.

Salomé LeibundGut-Landmann1, Olaf Gross, Matthew J Robinson, Fabiola Osorio, Emma C Slack, S Vicky Tsoni, Edina Schweighoffer, Victor Tybulewicz, Gordon D Brown, Jürgen Ruland, Caetano Reis e Sousa.   

Abstract

The C-type lectin dectin-1 binds to yeast and signals through the kinase Syk and the adaptor CARD9 to induce production of interleukin 10 (IL-10) and IL-2 in dendritic cells (DCs). However, whether this pathway promotes full DC activation remains unclear. Here we show that dectin-1-Syk-CARD9 signaling induced DC maturation and the secretion of proinflammatory cytokines, including IL-6, tumor necrosis factor and IL-23, but little IL-12. Dectin-1-activated DCs 'instructed' the differentiation of CD4+ IL-17-producing effector T cells (T(H)-17 cells) in vitro, and a dectin-1 agonist acted as an adjuvant promoting the differentiation of T(H)-17 and T helper type 1 cells in vivo. Infection with Candida albicans induced CARD9-dependent T(H)-17 responses to the organism. Our data indicate that signaling through Syk and CARD9 can couple innate to adaptive immunity independently of Toll-like receptor signals and that CARD9 is required for the development of T(H)-17 responses to some pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450144     DOI: 10.1038/ni1460

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  493 in total

Review 1.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

2.  IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Authors:  Shinji Kagami; Heather L Rizzo; Stephen E Kurtz; Lloyd S Miller; Andrew Blauvelt
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 3.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

4.  CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans.

Authors:  Liangkuan Bi; Sara Gojestani; Weihui Wu; Yen-Michael S Hsu; Jiayuan Zhu; Kiyoshi Ariizumi; Xin Lin
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 5.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

Review 6.  C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.

Authors:  Lara M Kingeter; Xin Lin
Journal:  Cell Mol Immunol       Date:  2012-01-16       Impact factor: 11.530

Review 7.  Regulation of TH17 cell differentiation by innate immune signals.

Authors:  Gonghua Huang; Yanyan Wang; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 8.  The response of human dendritic cells to co-ligation of pattern-recognition receptors.

Authors:  Tanja Dzopalic; Ivan Rajkovic; Ana Dragicevic; Miodrag Colic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

9.  Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Authors:  George S Deepe; William R Buesing; Gary R Ostroff; Ambily Abraham; Charles A Specht; Haibin Huang; Stuart M Levitz
Journal:  Vaccine       Date:  2018-05-02       Impact factor: 3.641

10.  Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Claudia Salazar-Aldrete; Marta Galán-Díez; Elena Fernández-Ruiz; Perla Niño-Moreno; Lizbeth Estrada-Capetillo; Carlos Abud-Mendoza; Esther Layseca-Espinosa; Lourdes Baranda; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.